Reduced Chemotherapy in Low Risk DLBCL

Clinical trial NCT02752815 · UNKNOWN

Trial details

NCT number: NCT02752815
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2016-06-14
Primary completion: 2022-10-30
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.